Pasquini J, Firbank M, Best L, Foster V, Stewart C, Silani V
Brain Commun. 2025; 7(1):fcaf023.
PMID: 39926608
PMC: 11806417.
DOI: 10.1093/braincomms/fcaf023.
Zhou W, Chu H
Acta Pharmacol Sin. 2024; .
PMID: 39592731
DOI: 10.1038/s41401-024-01428-z.
Nardelli D, Gambioli F, De Bartolo M, Mancinelli R, Biagioni F, Carotti S
Brain Commun. 2024; 6(4):fcae210.
PMID: 39130512
PMC: 11311710.
DOI: 10.1093/braincomms/fcae210.
Ye R, Hezemans F, OCallaghan C, Tsvetanov K, Rua C, Jones P
J Neurosci. 2023; 43(42):7028-7040.
PMID: 37669861
PMC: 10586538.
DOI: 10.1523/JNEUROSCI.0289-22.2023.
Chaudhuri K, Leta V, Bannister K, Brooks D, Svenningsson P
Nat Rev Neurol. 2023; 19(6):333-345.
PMID: 37142796
DOI: 10.1038/s41582-023-00802-5.
Task-Evoked Pupillary Response as a Potential Biomarker of Dementia and Mild Cognitive Impairment: A Scoping Review.
Zeeman M, Figeys M, Brimmo T, Burnstad C, Hao J, Kim E
Am J Alzheimers Dis Other Demen. 2023; 38:15333175231160010.
PMID: 36896819
PMC: 10580717.
DOI: 10.1177/15333175231160010.
Insights into Neurodegeneration in Parkinson's Disease from Single-Cell and Spatial Genomics.
Kamath T, Macosko E
Mov Disord. 2023; 38(4):518-525.
PMID: 36881930
PMC: 11056908.
DOI: 10.1002/mds.29374.
Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism.
Beserra-Filho J, Maria-Macedo A, Silva-Martins S, Custodio-Silva A, Soares-Silva B, Silva S
Metab Brain Dis. 2022; 37(7):2331-2347.
PMID: 35779151
DOI: 10.1007/s11011-022-01032-2.
Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders.
Ye R, OCallaghan C, Rua C, Hezemans F, Holland N, Malpetti M
Mov Disord. 2022; 37(8):1663-1672.
PMID: 35576973
PMC: 9541468.
DOI: 10.1002/mds.29072.
Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson's Disease.
Madelung C, Meder D, Fuglsang S, Marques M, Boer V, Madsen K
Mov Disord. 2022; 37(3):479-489.
PMID: 35114035
PMC: 9303353.
DOI: 10.1002/mds.28945.
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?.
Blesa J, Foffani G, Dehay B, Bezard E, Obeso J
Nat Rev Neurosci. 2021; 23(2):115-128.
PMID: 34907352
DOI: 10.1038/s41583-021-00542-9.
Restoration of Noradrenergic Function in Parkinson's Disease Model Mice.
Cui K, Yang F, Tufan T, Raza M, Zhan Y, Fan Y
ASN Neuro. 2021; 13:17590914211009730.
PMID: 33940943
PMC: 8114769.
DOI: 10.1177/17590914211009730.
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
OCallaghan C, Hezemans F, Ye R, Rua C, Jones P, Murley A
Brain. 2021; 144(8):2513-2526.
PMID: 33783470
PMC: 7611672.
DOI: 10.1093/brain/awab142.
Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia.
Giorgi F, Biagioni F, Galgani A, Pavese N, Lazzeri G, Fornai F
Int J Mol Sci. 2020; 21(22).
PMID: 33207731
PMC: 7697920.
DOI: 10.3390/ijms21228630.
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.
Alarcon-Aris D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferres-Coy A, Ruiz-Bronchal E
EBioMedicine. 2020; 59:102944.
PMID: 32810825
PMC: 7452525.
DOI: 10.1016/j.ebiom.2020.102944.
The Noradrenergic System in Parkinson's Disease.
Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C
Front Pharmacol. 2020; 11:435.
PMID: 32322208
PMC: 7157437.
DOI: 10.3389/fphar.2020.00435.
Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.
Zhan Y, Raza M, Yuan L, Zhu M
Neuroscience. 2019; 422:184-201.
PMID: 31698021
PMC: 9338788.
DOI: 10.1016/j.neuroscience.2019.09.036.
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.
Giguere N, Burke Nanni S, Trudeau L
Front Neurol. 2018; 9:455.
PMID: 29971039
PMC: 6018545.
DOI: 10.3389/fneur.2018.00455.
Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion.
Sabbar M, Delaville C, De Deurwaerdere P, Lakhdar-Ghazal N, Benazzouz A
Front Neurosci. 2018; 12:173.
PMID: 29615861
PMC: 5868125.
DOI: 10.3389/fnins.2018.00173.
Biomarkers for Parkinson's Disease: Recent Advancement.
Lotankar S, Prabhavalkar K, Bhatt L
Neurosci Bull. 2017; 33(5):585-597.
PMID: 28936761
PMC: 5636742.
DOI: 10.1007/s12264-017-0183-5.